RxDoctor Payments Data

Hannah Norris

Family · London, KYNPI 1669254629

Payments from drug & device makers

$2,173in general payments, 2019–2025

Across 128 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$469
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$262
  • Vanda Pharmaceuticals Inc.$254
  • Teva Pharmaceuticals USA, Inc.$199
  • Johnson & Johnson$194
  • Otsuka America Pharmaceutical, Inc.$151
  • plus $644 from 13 others

What the payments were for

  • Food & beverage$2,12898%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,173 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide18$24,942
OzempicSemaglutide11$9,673
Albuterol Sulfate HfaAlbuterol Sulfate38$1,086
Ventolin HfaAlbuterol Sulfate19$1,034
Gabapentin52$552
Ondansetron OdtOndansetron26$339
Diclofenac Sodium16$305
Ropinirole Hcl29$305
Doxycycline Monohydrate24$204
Omeprazole25$187
Duloxetine Hcl23$167
Lisinopril51$159
Pantoprazole Sodium34$135
Levothyroxine Sodium24$129
Atorvastatin Calcium44$125

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$45$24,94218 claims
Novo NordiskOzempic$73$9,67311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in London

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →